This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kassab, S. Articles by Granger, J. Search for Related Content PubMed PubMed Citation Articles by Kassab, S. Articles by Granger, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Dietary Sodium High Blood Pressure

(Hypertension. 1997;30:682.)
© 1997 American Heart Association, Inc.

Articles

Role of Endothelin in Mediating the Attenuated Renal Hemodynamics in Dahl Salt-Sensitive Hypertension

Salah Kassab; Jackie Novak; Todd Miller; Kent Kirchner; Joey Granger

From the Department of Physiology and Biophysics, University of Mississippi Medical Center (Jackson).

Correspondence to Joey P. Granger, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail JPG{at}fiona.umsmed.edu

Abstract The aim of this study was to evaluate the role of endothelin (ET) in the hypertension associated with giving a high sodium diet in Dahl salt-sensitive (DS) rats. To achieve this goal, we examined the effects of intravenous infusion of the nonspecific ET_A-ET_B antagonist on arterial pressure and renal function in conscious, chronically instrumented DS and Dahl salt-resistant (DR) rats. After 3 weeks on a high sodium (8%) diet, mean arterial pressure (MAP) in DS rats (166±3 mm Hg) was significantly higher than in DR rats (124±3 mm Hg). Baseline glomerular filtration rate (GFR) and renal plasma flow (RPF) in DS rats (1.92±0.25 mL/min and 7.07±0.80 mL/min) were lower than in DR rats (2.52±0.21 mL/min and 7.98±0.85 mL/min), respectively. Renal vascular resistance was significantly higher in DS rats (32.78±5.88 mm Hg · mL^-1 · min^-1) than in DR rats (24.60±5.04 mm Hg · mL^-1 · min^-1). Intravenous infusion of the ET antagonist SB 209670 at a dose of 30 µg · kg^-1 · min^-1 for 75 minutes caused a significant decrease in MAP in DS rats (from 166±3 to 144±4 mm Hg). In contrast, the effect of the ET antagonism on MAP in DR rats was not significant. ET-antagonist infusion tended to improve GFR and RPF in DS but not in DR rats. To determine the renal effects of ET antagonism independent of the systemic hemodynamic responses, we examined the effects of the same ET antagonist in rats chronically implanted with a renal interstitial catheter. Arterial pressure in DS rats (181±5 mm Hg) was significantly higher than in DR rats (135±3 mm Hg). Renal interstitial infusion of SB 209670 at a dose of 200 ng · kg^-1 · min^-1 for 60 minutes caused no change in MAP in DS or DR rats. Intrarenal ET antagonism significantly increased GFR (25%), RPF (30%), urine flow (32%), and urinary sodium excretion (25%) in DS rats, while it had no significant effect in DR rats. Fractional excretion of sodium was not significantly changed by renal interstitial infusion of the ET antagonist in DS rats, indicating that improved renal excretory function in DS rats is most likely due to the associated improvement in renal hemodynamics. We conclude that ET may play a role in the attenuated renal hemodynamics and possibly the development of Dahl salt-sensitive hypertension.

Key Words: endothelins • kidney • rats, Dahl • sodium

This article has been cited by other articles:

				Y. Wang and D. H. Wang A Novel Mechanism Contributing to Development of Dahl Salt-Sensitive Hypertension: Role of the Transient Receptor Potential Vanilloid Type 1 Hypertension, March 1, 2006; 47(3): 609 - 614. [Abstract] [Full Text] [PDF]

				Y. Wang, A. F. Chen, and D. H. Wang ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2005 - H2011. [Abstract] [Full Text] [PDF]

				C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero Role of Endothelin in the Pathogenesis of Hypertension Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96. [Abstract] [PDF]

				M. H. Sedeek, M. T. Llinas, H. Drummond, L. Fortepiani, S. R. Abram, B. T. Alexander, J. F. Reckelhoff, and J. P. Granger Role of Reactive Oxygen Species in Endothelin-Induced Hypertension Hypertension, October 1, 2003; 42(4): 806 - 810. [Abstract] [Full Text] [PDF]

				J. P. Granger Endothelin Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301. [Full Text] [PDF]

				R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper Increased collecting duct urea transporter expression in Dahl salt-sensitive rats Am J Physiol Renal Physiol, July 1, 2003; 285(1): F143 - F151. [Abstract] [Full Text] [PDF]

				L. Smith, J. A. Payne, M. H. Sedeek, J. P. Granger, and R. A. Khalil Endothelin-Induced Increases in Ca2+ Entry Mechanisms of Vascular Contraction Are Enhanced During High-Salt Diet Hypertension, March 1, 2003; 41(3): 787 - 793. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]

				P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]

				S. Kassab, M. T. Miller, J. Novak, J. Reckelhoff, B. Clower, and J. P. Granger Endothelin-A Receptor Antagonism Attenuates the Hypertension and Renal Injury in Dahl Salt-Sensitive Rats Hypertension, January 1, 1998; 31(1): 397 - 402. [Abstract] [Full Text] [PDF]